Your browser doesn't support javascript.
loading
Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC: Primary and Correlative Biomarker Analyses.
Owonikoko, Taofeek K; Niu, Huifeng; Nackaerts, Kristiaan; Csoszi, Tibor; Ostoros, Gyula; Mark, Zsuzsanna; Baik, Christina; Joy, Anil Abraham; Chouaid, Christos; Jaime, Jesus Corral; Kolek, Vitezslav; Majem, Margarita; Roubec, Jaromir; Santos, Edgardo S; Chiang, Anne C; Speranza, Giovanna; Belani, Chandra P; Chiappori, Alberto; Patel, Manish R; Czebe, Krisztina; Byers, Lauren; Bahamon, Brittany; Li, Cong; Sheldon-Waniga, Emily; Kong, Eric F; Williams, Miguel; Badola, Sunita; Shin, Hyunjin; Bedford, Lisa; Ecsedy, Jeffrey A; Bryant, Matthew; Jones, Sian; Simmons, John; Leonard, E Jane; Ullmann, Claudio Dansky; Spigel, David R.
Afiliación
  • Owonikoko TK; Winship Cancer Institute of Emory University, Atlanta, Georgia. Electronic address: towonik@emory.edu.
  • Niu H; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts.
  • Nackaerts K; KU Leuven, Universitaire Ziekenhuizen, Leuven, Belgium.
  • Csoszi T; Hetenyi G Korhaz, Szolnok, Hungary.
  • Ostoros G; Orszagos Koranyi TBC es Pulmonologiai Intezet, Budapest, Hungary.
  • Mark Z; Tudogyogyintezet Torokbalint, Torokbalint, Hungary.
  • Baik C; University of Washington Seattle Cancer Care Alliance, Seattle, Washington.
  • Joy AA; University of Alberta, Cross Cancer Institute, Edmonton, Alberta, Canada.
  • Chouaid C; CHI de Créteil, Créteil, France.
  • Jaime JC; Hospital Universitario Virgen del Rocio, Seville, Spain.
  • Kolek V; Fakultni Nemocnice Olomouc, Olomouc, Czech Republic.
  • Majem M; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Roubec J; Fakultni Nemocnice Ostrava, Ostrava Poruba, Czech Republic.
  • Santos ES; Lynn Cancer Institute/Boca Raton Regional Hospital, Boca Raton, Florida.
  • Chiang AC; Yale University School of Medicine, New Haven, Connecticut.
  • Speranza G; Université de Sherbrooke, Centre intégré de cancérologie de la Montéregie, Hôpital Charles Le Moyne, Greenfield Park, Quebec City, Canada.
  • Belani CP; Penn State Cancer Institute, Hershey, Pennsylvania.
  • Chiappori A; H. Lee Moffitt Cancer Center, Tampa, Florida.
  • Patel MR; Florida Cancer Specialists/Sarah Cannon Research Institute, Sarasota, Florida.
  • Czebe K; Tudogyogyintezet Torokbalint, Törökbálint, Hungary.
  • Byers L; Tudogyogyintezet Torokbalint, Törökbálint, Hungary.
  • Bahamon B; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts.
  • Li C; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts.
  • Sheldon-Waniga E; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts.
  • Kong EF; University of Texas M. D. Anderson Cancer Center, Houston, Texas.
  • Williams M; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts.
  • Badola S; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts.
  • Shin H; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts.
  • Bedford L; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts.
  • Ecsedy JA; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts.
  • Bryant M; University of Texas M. D. Anderson Cancer Center, Houston, Texas.
  • Jones S; University of Texas M. D. Anderson Cancer Center, Houston, Texas.
  • Simmons J; University of Texas M. D. Anderson Cancer Center, Houston, Texas.
  • Leonard EJ; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts.
  • Ullmann CD; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts.
  • Spigel DR; Personal Genome Diagnostics, Baltimore, Maryland.
J Thorac Oncol ; 15(2): 274-287, 2020 02.
Article en En | MEDLINE | ID: mdl-31655296
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Paclitaxel / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Thorac Oncol Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Paclitaxel / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Thorac Oncol Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos